$2.35T
Total marketcap
$85.4B
Total volume
BTC 50.03%     ETH 15.39%
Dominance

ORIENT BIO Inc. 002630.KS Stock

548 KRW {{ price }} -2.836880% {{change_pct}}%
Exchange
KSE
Market Cap
64.98B KRW
LOW - HIGH [24H]
547 - 563 KRW
VOLUME [24H]
129.2K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW

ORIENT BIO Inc. Price Chart

ORIENT BIO Inc. 002630.KS Financial and Trading Overview

ORIENT BIO Inc. stock price 548 KRW
Previous Close 690 KRW
Open 692 KRW
Bid 684 KRW x 0
Ask 685 KRW x 0
Day's Range 667 - 717 KRW
52 Week Range 576 - 890 KRW
Volume 707.93K KRW
Avg. Volume 1.27M KRW
Market Cap 81.1B KRW
Beta (5Y Monthly) 1.121917
PE Ratio (TTM) N/A
EPS (TTM) 0 KRW
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

002630.KS Valuation Measures

Enterprise Value 80.07B KRW
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.372461
Price/Book (mrq) N/A
Enterprise Value/Revenue 1.355
Enterprise Value/EBITDA 59.796

Trading Information

ORIENT BIO Inc. Stock Price History

Beta (5Y Monthly) 1.121917
52-Week Change -9.44%
S&P500 52-Week Change 20.43%
52 Week High 890 KRW
52 Week Low 576 KRW
50-Day Moving Average 663.36 KRW
200-Day Moving Average 653.74 KRW

002630.KS Share Statistics

Avg. Volume (3 month) 1.27M KRW
Avg. Daily Volume (10-Days) 566.99K KRW
Shares Outstanding 118.57M
Float 47.9M
Short Ratio N/A
% Held by Insiders 35.60%
% Held by Institutions 0.28%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate N/A
Trailing Annual Dividend Yield N/A
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 0.445441:1

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2021
Most Recent Quarter (mrq) December 31, 2021
Next Fiscal Year End March 31, 2022

Profitability

Profit Margin -11.59%
Operating Margin (ttm) -4.85%
Gross Margin 35.96%
EBITDA Margin 2.26%

Management Effectiveness

Return on Assets (ttm) -2.19%
Return on Equity (ttm) -12.41%

Income Statement

Revenue (ttm) 59.09B KRW
Revenue Per Share (ttm) 498.43 KRW
Quarterly Revenue Growth (yoy) 21.80%
Gross Profit (ttm) 18.77B KRW
EBITDA 1.34B KRW
Net Income Avi to Common (ttm) -6853405696 KRW
Diluted EPS (ttm) N/A
Quarterly Earnings Growth (yoy) -77.00000000000000000000000000000000%

Balance Sheet

Total Cash (mrq) 12.4B KRW
Total Cash Per Share (mrq) 104.6 KRW
Total Debt (mrq) 10.66B KRW
Total Debt/Equity (mrq) 20.18 KRW
Current Ratio (mrq) 1.801
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) 11.74B KRW
Levered Free Cash Flow (ttm) -1355197440 KRW

Profile of ORIENT BIO Inc.

Country South Korea
State N/A
City Seongnam-si
Address 322, Galmachi-ro
ZIP N/A
Phone 82 3 1730 6100
Website https://www.orient.co.kr
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

ORIENT BIO Inc. operates in the bio-industry in South Korea. The company produces laboratory animals. In addition, it offers various equipment for research environment. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is based in Seongnam, South Korea.

Q&A For ORIENT BIO Inc. Stock

What is a current 002630.KS stock price?

ORIENT BIO Inc. 002630.KS stock price today per share is 548 KRW.

How to purchase ORIENT BIO Inc. stock?

You can buy 002630.KS shares on the KSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ORIENT BIO Inc.?

The stock symbol or ticker of ORIENT BIO Inc. is 002630.KS.

Which industry does the ORIENT BIO Inc. company belong to?

The ORIENT BIO Inc. industry is Biotechnology.

How many shares does ORIENT BIO Inc. have in circulation?

The max supply of ORIENT BIO Inc. shares is 118.57M.

What is ORIENT BIO Inc. Price to Earnings Ratio (PE Ratio)?

ORIENT BIO Inc. PE Ratio is now.

What was ORIENT BIO Inc. earnings per share over the trailing 12 months (TTM)?

ORIENT BIO Inc. EPS is 0 KRW over the trailing 12 months.

Which sector does the ORIENT BIO Inc. company belong to?

The ORIENT BIO Inc. sector is Healthcare.